Physician profile
Divyang Patel
NPI 1043638794
$34,706.32
in general payments reported to CMS, 2019-2025
15 companies · $14K in 2025
The $14K reported for 2025 was more than what 85% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,223 · 2020: $7,717 · 2021: $5,662 · 2022: $1,399 · 2023: $2,798 · 2024: $1,603 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,322 · Food and Beverage: $5,786 · Consulting Fee: $3,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,321.76 |
| Food and Beverage | $5,785.82 |
| Consulting Fee | $3,597.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $10,992.01 | 2023-2025 | Carto 3, Na |
| Abbott Laboratories | $8,672.29 | 2020-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Gallant |
| Boston Scientific Corporation | $7,672.07 | 2019-2025 | Farapulse, Rhythmia Mapping System, Watchman Flx |
| Medtronic, INC. | $2,102.07 | 2021-2025 | Micra, Affera Mapping System, Pulseselect |
| Philips North America LLC | $1,594.24 | 2022-2025 | Lm Undivided, Igt Devices Undivided, Lld |
| Medical Device Business Services, INC. | $1,470.79 | 2023-2024 | Carto 3 |
| Medtronic Vascular, INC. | $1,163.54 | 2019 | |
| Biotronik INC. | $689.90 | 2023-2025 | Acticor 7 Vr-T Dx, Rivacor 7 Dr-T, Selectra |
| Stryker Corporation | $102.50 | 2025 | Flowtriever |
| Irhythm Technologies, INC. | $94.79 | 2023 | Zio Xt Patch |
| Cordis US Corp. | $41.12 | 2024-2025 | Mynx Venous Vcd |
| Pfizer INC. | $39.94 | 2024-2025 | |
| Cardiva Medical, INC. | $37.55 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $17.83 | 2024 | Verquvo |
| Genzyme Corporation | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divyang Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.